ACTELION PHARMACEUTICALS LTD
Desconocido
UMBRELLA: Unleashing a CoMprehensive Holistic and Patient Centric Stroke Management for a Better Rapid Adva...
"UMBRELLA is a holistic approach to progress, reshape, and benchmark the overall stroke care pathway and set new and improved standards of c...
2024-07-31 - 2029-09-30 | Financiado
2024-07-31 - 2029-09-30 | Financiado
PREFER: Patient Preferences in benefit risk assessments during the drug life cycle Sofia ref. 115966
ACTELION PHARMACEUTICALS LTD
participó en un
H2020:
H2020-JTI-IMI2-2015-05-two-stage
The PREFER project will deliver an overview and evaluation of preference elicitation methods to be applied in the entire drug life cycle, i....
2016-10-21 - 2022-05-31 | Financiado
2016-10-21 - 2022-05-31 | Financiado
ONCORNET: ONCOgenic Receptor Network of Excellence and Training
ACTELION PHARMACEUTICALS LTD
participó en un
H2020:
H2020-MSCA-ITN-2014
Cancer is a leading health concern. There is a need to fully understand the fundamental processes underlying development of cancer. There is...
2014-12-16 - 2019-05-31 | Financiado
2014-12-16 - 2019-05-31 | Financiado
TUMIC: An integrated concept of tumor metastasis implications for therapy
ACTELION PHARMACEUTICALS LTD
participó en un
FP7:
From many perspectives our concept of the process of metastasis is inadequate and needs to be revised. In particular, the potential impact o...
Financiado
Financiado
* No se disponen de datos de la empresa actual.